pharm Dm pt 1

Overview of Beta Cells and Diabetes

  • Beta Cells

    • Located in the pancreas.

    • Their destruction leads to type 1 diabetes (T1D).

    • Cause of destruction is not fully understood.

    • Certain viruses and immune responses may be linked to the development of T1D.

  • Type 1 Diabetes (T1D)

    • Typically diagnosed in young individuals, ages 15-25.

    • Characterized by autoimmune destruction of beta cells.

    • Immune system mistakenly attacks insulin-producing beta cells in the pancreas.

    • HLA (Human Leukocyte Antigen)

    • Important molecules involved in the immune response.

    • HLA D2D and HLA EQR gene groups are associated with a higher risk of developing T1D.

Insulin and Its Role

  • Insulin

    • Hormone crucial for regulating blood glucose levels.

    • Without insulin, cells cannot take up glucose, which leads to high blood sugar levels.

    • Treatment for T1D requires administration of insulin.

  • Discovery of Insulin

    • Insulin was discovered to be effective in managing diabetes by providing injections derived from the pancreas of dogs.

    • Early mentions of insulin in Turkish physiologist's work focused on its potential to lower blood glucose in dogs without translating into a human clinical setting.

Mechanism of Insulin Action

  • Glucose Transport

    • Insulin activates GLUT4 (glucose transporter) to allow glucose entry into cells (especially muscle and adipose tissues).

    • Cellular uptake of glucose leads to ATP production, providing energy to cells.

  • Consequences of Insulin Absence

    • Lack of insulin leads to:

    • Increased fat utilization instead of glucose.

    • Ketogenesis (process where fat is converted into ketone bodies).

    • Risk of metabolic acidosis due to high levels of ketones.

  • Osmotic Effects of Glucose

    • High glucose levels lead to osmotic diuresis, resulting in dehydration and hypovolemia.

    • Severe metabolic issues can arise from prolonged high blood glucose levels without treatment.

Type 2 Diabetes (T2D)

  • Difference from T1D

    • T2D is characterized by insulin resistance rather than an absence of insulin.

    • Individuals may have high insulin levels as their bodies struggle to respond to it (hyperinsulinemia).

    • Commonly develops due to lifestyle factors, and genetics may also play a role.

  • Insulin Resistance in T2D

    • Conditions leading to insulin resistance include obesity and sedentary lifestyle.

    • Insulin is still produced, but its effectiveness in promoting glucose uptake is diminished.

  • Metabolic Consequences of T2D

    • Prolonged high levels of insulin lead to increased fat storage and muscle growth.

    • Risks include excessive hunger, increased appetite, and obesity, which further complicate insulin resistance.

    • Potential link between chronic high insulin levels and the development of cancer due to abnormal tissue growth.

Etiology and Treatment of Diabetes

  • Modifiable and Non-modifiable Risk Factors

    • While lifestyle choices play a crucial role in T2D, there are also genetic components that contribute to the disease.

    • Familial tendencies for obesity and insulin resistance increase susceptibility to T2D.

  • Diagnosis of Diabetes

    • Fasting Blood Glucose Test: A reading of 126 mg/dL (7.0 mmol/L) or higher indicates diabetes.

    • Glucose Tolerance Test: A reading of 200 mg/dL (11.1 mmol/L) or higher after two hours indicates diabetes.

    • HbA1c Levels: >5.7% can signal prediabetes or diabetes.

Insulin Secretion Mechanism

  • Mechanism of Insulin Release

    • Glucose enters beta cells and is metabolized to produce ATP.

    • Increase in ATP leads to closure of ATP-sensitive potassium channels, causing cell depolarization.

    • This triggers calcium influx, ultimately causing insulin release.

  • Sulfonylureas

    • A class of medications that stimulate insulin secretion by blocking potassium channels.

    • Can lead to increased body weight over time due to heightened insulin levels.

Hormonal Regulation of Insulin

  • Influence of Nervous System

    • Muscarinic receptor activity increases insulin release (via acetylcholine), while adrenergic (alpha-2) activity decreases insulin release during stress.

Insulin Preparations and Administration Techniques

  • Types of Insulin

    • Rapid-Acting Insulin: Begins working in minutes; used for immediate glucose control.

    • Short-Acting Insulin: Regular insulin, acts within hours; used in acute situations like DKA.

    • Intermediate-Acting Insulin: Prolonged effects; good for covering baseline insulin needs.

    • Long-Acting Insulin: Provides a steady level of insulin over longer periods.

  • Administration Recommendations

    • Insulin preparations should be matched to specific patient needs, including meals and activity levels.

    • Patients should avoid mixing different types of insulin in injections unless directed by a healthcare professional.

Education and Implementation

  • Educating Diabetic Patients

    • Understanding the difference between T1D and T2D is crucial for managing therapy effectively.

    • It is important to monitor blood glucose levels regularly and adjust insulin or medications accordingly.

    • Patients must recognize symptoms of both hypoglycemia and hyperglycemia and understand their implications for long-term health.

  • Support Resources

    • Access to healthcare professionals for diabetes management and regular check-ups is vital for early detection of complications.